Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 4 results
Start Over Descriptor "Antiviral agents -- Product introduction" Publisher ubm information ltd.
4 results on '"Antiviral agents -- Product introduction"'

1. Clinical News: Treatment launched for hepatitis

Subjects
Novartis Pharma AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis B -- Drug therapy, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Sebivo (Medication) -- Product introduction
Abstract

Novartis Pharmaceuticals has launched a treatments for hepatitis B. Telbivudine (Sebivo) is licensed for the treatment of chronic hepatitis B in adults with compensated liver disease, evidence of viral replication, [...]

Published
2007

2. OVER THE COUNTER: New prescription product - Emtriva oral solution

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Liquid containing emtricitabine 10mg/ml For use in HIV-1 infections or in combination with other anti- retrovirals Usual dose: 240mg (24ml) once daily in adults and 6mg/kg (up to 240mg) in [...]

Published
2005

3. Telzir Oral Suspension

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

GlaxoSmithKline has launched Telzir (fosamprenavir) 50mg/ml Oral Suspension. It is licensed in combination with low dose ritonavir for the treatment of HIV in adults over 18 years old. It should [...]

Published
2004

4. Emtriva for HIV

Subjects
Gilead Sciences Inc. -- Product introduction, AIDS patients -- Drug therapy, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Emtriva (Medication) -- Product introduction
Abstract

Gilead has launched a new nucleoside and nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infected adults and children in conjunction with other antiretroviral agents. Emtriva (emtricitabine 200mg capsules) [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results